查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595146

PCR 技術市場：按技術、產品類型、應用和最終用戶分類 - 2025-2030 年全球預測

PCR Technologies Market by Technique (Conventional PCR, Digital PCR, Hot-Start PCR), Product Type (Instruments, Reagents & Consumables, Software & Services), Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年PCR技術市值為49.8億美元，預計到2024年將達到54.3億美元，複合年成長率為9.64%，到2030年將達到94.9億美元。

聚合酵素鏈鎖反應（PCR）技術作為擴增DNA序列的重要工具，在分子診斷市場中涵蓋廣泛。對於研究、法醫學、醫療診斷和生物防禦等各種應用至關重要。 PCR 的需求至關重要，因為它速度快、準確性高，並且能夠處理最少的 DNA 樣本，從而可以進行詳細的遺傳分析，有助於疾病檢測、個人化醫療和遺傳研究。最終用途包括臨床實驗室、醫院、學術機構、生技公司等。 PCR技術市場的主要成長要素包括基因組研究的進步、感染疾病的流行以及精準醫療需求的不斷成長。最近的趨勢強調將 PCR 與數位和就地檢驗相結合，以增強快速診斷。 COVID-19 大流行加速了 PCR 技術在病毒識別中的關鍵作用，並創造了新的機遇，例如可攜式PCR 設備的開發。然而，挑戰包括高成本、技術複雜性以及次世代定序等替代技術的出現。此外，潛在的監管障礙和對技術人員的需求也構成了進一步的限制。 PCR 技術的創新可能會擴大應用範圍，重點是提高靈敏度和速度、降低成本以及用於資料分析的人工智慧整合。儘管市場仍然競爭激烈，但對於專注於利基應用或開發方便用戶使用且經濟高效的解決方案來提高可訪問性的參與企業來說，時機已經成熟。鼓勵希望在個人化醫療和感染疾病控制領域抓住新商機的公司投資於策略聯盟和研發。儘管 PCR 技術不斷發展，有望簡化工作流程並提高效率，相關人員必須應對競爭壓力和監管環境。促進創新非常重要，市場趨勢是自動化流程和簡化 PCR 應用，以擴展其在不同領域的範圍和效用。

主要市場統計
基準年[2023] 49.8億美元
預測年份 [2024] 54.3億美元
預測年份 [2030] 94.9億美元
複合年成長率（%） 9.64%

市場動態：揭示快速發展的 PCR 技術市場的關鍵市場洞察

PCR 技術市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球嚴重增加
    • 政府對研發的支持
    • 即時定量 PCR (RT-qPCR) 在研究中的應用增加
    • 在法醫部門中非常重要
  • 市場限制因素
    • 假陰性和再感染的可能性
  • 市場機會
    • 診斷中心和醫院數量的增加
    • 基於基因組的藥物發現方法的興起
    • COVID-19 導致 RT-PCR 快速成長
  • 市場挑戰
    • 替代測試的可用性
    • 缺乏保險報銷政策

波特五力：駕馭 PCR 技術市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解PCR技術市場的外部影響

外部宏觀環境因素在塑造PCR技術市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解PCR技術市場的競爭狀況

PCR 技術市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣PCR技術市場供應商績效評估

FPNV定位矩陣是評估PCR技術市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

制定 PCR 技術市場成功之路的策略分析和建議

PCR 技術市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地嚴重的發生率上升
      • 政府對研發的支持
      • 即時定量 PCR (RT-qPCR) 在研究中的應用不斷增加
      • 在法醫學部門中非常重要
    • 抑制因素
      • 假陰性和可能的​​再感染
    • 機會
      • 診斷中心和醫院數量的增加
      • 基於基因組的藥物發現方法的興起
      • 由於 COVID-19，RT-PCR 迅速增加
    • 任務
      • 替代測試的可用性
      • 缺乏支持性報銷政策
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 PCR 技術市場：依技術分類

  • 常規PCR
  • 數位PCR
  • 熱啟動PCR
  • 多重PCR
  • 即時PCR
  • 逆轉錄聚合酶連鎖反應

第7章 PCR 技術市場：依產品類型

  • 裝置
  • 試劑/耗材
  • 軟體和服務

第8章 PCR 技術市場：依應用分類

  • 診斷應用
  • 環境應用
  • 基因表現分析
  • 基因序列分析
  • 基因型鑒定
  • 核酸檢測
  • 核酸合成
  • 標準檢驗/檢驗

第 9 章 PCR 技術市場：依最終用戶分類

  • 學術和政府機構
  • 應用產業
  • 醫療保健產業
  • 醫院和診斷中心
  • 製藥生物技術公司

第10章 美洲PCR技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區PCR技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲PCR技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • Fluidigm Corporation by Standard BioTools Inc.
  • Merck KGaA
  • Promega Corporation
  • Qiagen NV
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-FD3F12D53D2D

The PCR Technologies Market was valued at USD 4.98 billion in 2023, expected to reach USD 5.43 billion in 2024, and is projected to grow at a CAGR of 9.64%, to USD 9.49 billion by 2030.

Polymerase Chain Reaction (PCR) Technologies have a broad scope within the molecular diagnostics market, serving as a crucial tool for amplifying DNA sequences. It's integral in various applications like research, forensics, medical diagnostics, and biodefense. PCR's necessity is paramount for its speed, accuracy, and capacity to work with minimal DNA samples, enabling detailed genetic analysis that aids in disease detection, personalized medicine, and genetic research. End-use includes clinical laboratories, hospitals, academic institutions, and biotech companies. Key growth factors in the PCR technology market involve advancements in genome studies, growing prevalence of infectious diseases, and escalating demand for precision medicine. Recent trends highlight the integration of PCR with digital and point-of-care testing, enhancing rapid diagnostics. The COVID-19 pandemic has accelerated PCR technology adoption due to its critical role in identifying the virus, spawning new opportunities like the development of portable PCR devices. However, challenges include high costs, technical complexities, and the advent of alternate technologies such as next-generation sequencing. Furthermore, potential regulatory hurdles and the need for skilled personnel pose added constraints. Innovations in PCR technology could focus on improving sensitivity and speed, reducing costs, and integrating AI for data analysis to expand applications. The market remains competitive but ripe for entrants focusing on niche applications or developing user-friendly, cost-efficient solutions that enhance accessibility. Strategic collaborations and investments in R&D are recommended for companies aiming to capture emerging opportunities in personalized medicine and infectious disease control. While PCR technology continues to evolve with advancements promising to streamline workflows and increase efficiency, stakeholders must navigate competitive pressures and regulatory landscapes. Fostering innovation is crucial, with a market inclination towards automating processes and simplifying PCR applications to broaden its scope and utility across diverse sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 4.98 billion
Estimated Year [2024] USD 5.43 billion
Forecast Year [2030] USD 9.49 billion
CAGR (%) 9.64%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving PCR Technologies Market

The PCR Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of critical diseases across the world
    • Government support for R&D
    • Rise in Real-time Quantitative PCR (RT-qPCR) application in research
    • High importance in forensics department
  • Market Restraints
    • False negatives and reinfections possibilities
  • Market Opportunities
    • Growth in number of diagnostic centers and hospitals
    • Rising approach towards genome-based drug discovery
    • Rapid growth in RT-PCR due to COVID-19
  • Market Challenges
    • Availability of alternative test
    • Lack of supportive reimbursement policies

Porter's Five Forces: A Strategic Tool for Navigating the PCR Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the PCR Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the PCR Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the PCR Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the PCR Technologies Market

A detailed market share analysis in the PCR Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the PCR Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the PCR Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the PCR Technologies Market

A strategic analysis of the PCR Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the PCR Technologies Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Analytik Jena GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, Eppendorf SE, F. Hoffmann-La Roche Ltd., Fluidigm Corporation by Standard BioTools Inc., Merck KGaA, Promega Corporation, Qiagen N.V., Takara Bio, Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the PCR Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technique, market is studied across Conventional PCR, Digital PCR, Hot-Start PCR, Multiplex PCR, Real-Time PCR, and Reverse Transcription PCR.
  • Based on Product Type, market is studied across Instruments, Reagents & Consumables, and Software & Services.
  • Based on Application, market is studied across Diagnostic Applications, Environmental Applications, Gene Expression Analysis, Genetic Sequencing, Genotyping, Nucleic Acid Detection, Nucleic Acid Synthesis, and Standard Validation/Verification.
  • Based on End-user, market is studied across Academia & Government Organizations, Applied Industries, Healthcare Industry, Hospitals & Diagnostic Centers, and Pharma-Biotech Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of critical diseases across the world
      • 5.1.1.2. Government support for R&D
      • 5.1.1.3. Rise in Real-time Quantitative PCR (RT-qPCR) application in research
      • 5.1.1.4. High importance in forensics department
    • 5.1.2. Restraints
      • 5.1.2.1. False negatives and reinfections possibilities
    • 5.1.3. Opportunities
      • 5.1.3.1. Growth in number of diagnostic centers and hospitals
      • 5.1.3.2. Rising approach towards genome-based drug discovery
      • 5.1.3.3. Rapid growth in RT-PCR due to COVID-19
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative test
      • 5.1.4.2. Lack of supportive reimbursement policies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. PCR Technologies Market, by Technique

  • 6.1. Introduction
  • 6.2. Conventional PCR
  • 6.3. Digital PCR
  • 6.4. Hot-Start PCR
  • 6.5. Multiplex PCR
  • 6.6. Real-Time PCR
  • 6.7. Reverse Transcription PCR

7. PCR Technologies Market, by Product Type

  • 7.1. Introduction
  • 7.2. Instruments
  • 7.3. Reagents & Consumables
  • 7.4. Software & Services

8. PCR Technologies Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Applications
  • 8.3. Environmental Applications
  • 8.4. Gene Expression Analysis
  • 8.5. Genetic Sequencing
  • 8.6. Genotyping
  • 8.7. Nucleic Acid Detection
  • 8.8. Nucleic Acid Synthesis
  • 8.9. Standard Validation/Verification

9. PCR Technologies Market, by End-user

  • 9.1. Introduction
  • 9.2. Academia & Government Organizations
  • 9.3. Applied Industries
  • 9.4. Healthcare Industry
  • 9.5. Hospitals & Diagnostic Centers
  • 9.6. Pharma-Biotech Companies

10. Americas PCR Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific PCR Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa PCR Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Analytik Jena GmbH
  • 4. Becton, Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. Danaher Corporation
  • 8. Eppendorf SE
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. Fluidigm Corporation by Standard BioTools Inc.
  • 11. Merck KGaA
  • 12. Promega Corporation
  • 13. Qiagen N.V.
  • 14. Takara Bio, Inc.
  • 15. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. PCR TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. PCR TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PCR TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PCR TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PCR TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PCR TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PCR TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PCR TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY HOT-START PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY GENETIC SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY GENOTYPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY NUCLEIC ACID DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY NUCLEIC ACID SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY STANDARD VALIDATION/VERIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY ACADEMIA & GOVERNMENT ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLIED INDUSTRIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY HEALTHCARE INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PHARMA-BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. ITALY PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. POLAND PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. QATAR PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. RUSSIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SAUDI ARABIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH AFRICA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SPAIN PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. SWEDEN PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. SWITZERLAND PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. TURKEY PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED ARAB EMIRATES PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED KINGDOM PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. PCR TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 202. PCR TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023